May 5th, 2008

SpeculatingStocks.com Stock Pick: NeuroMetrix, Inc. (NURO)

Stock Price: $2.42

NeuroMetrix, Inc. is a science based medical device company advancing patient care through the development and marketing of innovative medical device products that aid physicians in the diagnosis and treatment of diseases of the nervous system and neurovascular disorders, and that provide regional anesthesia and pain control.

On April 28th, NURO received clearance for their ADVANCE(TM) system for the performance of nerve conduction studies. NURO is now allowed to market ADVANCE(TM) in the US market. NURO surged after receiving clearance, moving from the $1.65 level to $3.24.

NURO has since settled in at a bottom in its chart and looks ready to start another leg higher. Any catalyst could set it higher again.

The company has strong fundamentals with $29.76 million in cash and short term investments on the balance sheet with very little long term debt. NURO is trading at a market cap of only around $33.13 million.